问鼎娱乐.com|极速飞艇的冠亚和计划|极速赛车计划群群名|sg幸运飞艇计划官方版下载

<label id="6kt4j"></label>

    <li id="6kt4j"></li>
        1. Recombinant Human sFasR/TNFRSF6

          更多活動(dòng)更多優(yōu)惠,盡在翌圣商城》

          批量采購(gòu), 請(qǐng)點(diǎn)擊詢價(jià)

          產(chǎn)品說明書

          FAQ

          COA

          已發(fā)表文獻(xiàn)

          Fas and Fas Ligand (FasL) belong to the TNF superfamily, and are type I and type II transmembrane proteins, respectively. Binding of FasL to Fas triggers apoptosis in Fas-bearing cells. The mechanism of apoptosis involves recruitment of pro-caspase 8 through an adaptor molecule called FADD, followed by processing of the pro-enzyme into active forms. These active caspases then cleave various cellular substrates, leading to the eventual cell death. sFasR is capable of inhibiting FasL-induced apoptosis by acting as a decoy receptor that serves as a sink for FasL. The full length Fas (receptor) is a 319 amino acid type I transmembrane protein, which contains a 157 amino acid extracellular domain, a 17 amino acid transmembrane domain, and a 145 amino acid cytoplasmic domain. Recombinant Human soluble Fas (sFas Receptor) is a 157 amino acid polypeptide (17.6 kDa) corresponding to the TNFR-homologous cysteine-rich extracellular Fas domain.

           

          Product Properties

          Synonyms

          TNFRSF6, CD95, Apo I, Fas Antigen

          Accession

          P25445

          GeneID

          355

          Source

          E.coli-derived Human sFasR/TNFRSF6 protein,Arg17-Asn173.

          Molecular Weight

          Approximately 17.6 kDa

          AA Sequence

          RLSSKSVNAQ VTDINSKGLE LRKTVTTVET QNLEGLHHDG QFCHKPCPPG ERKARDCTVN GDEPDCVPCQ EGKEYTDKAH FSSKCRRCRL CDEGHGLEVE INCTRTQNTK CRCKPNFFCN STVCEHCDPC TKCEHGIIKE CTLTSNTKCK EEGSRSN

          Tag

          None

          Physical Appearance

          Sterile Filtered White lyophilized (freeze-dried) powder.

          Purity

          > 95 % by SDS-PAGE and HPLC analyses.

          Biological Activity

          Fully biologically active when compared to standard. The ED50 as determined by its ability to inhibit the cytotoxicity of Jurkat cells is between 10-15 µg/mL in the presence of 2 ng/ml of rHuFas Ligand.

          Endotoxin

          < 1.0 EU per 1μg of the protein by the LAL method.

          Formulation

          Lyophilized from a 0.2 μm filtered concentrated solution in 20 mM PB, pH 7.4, 150 mM NaCl.

          Reconstitution

          We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20°C. Further dilutions should be made in appropriate buffered solutions.

           

          Shipping and Storage

          The products are shipped with ice pack and can be stored at -20℃ to -80℃ for 1 year.

          Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.

           

          Cautions

          1. Avoid repeated freeze-thaw cycles.

          2. For your safety and health, please wear lab coats and disposable gloves for operation.

          3. For research use only.

          HB220309

           

          400-6111-883